HIV replication inhibitors (Immugen/Southern Research Institute)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHIV replication inhibitors (Immugen/Southern Research Institute)
Drug Alias NameIMG-507IMG-508IMG-511IMG-510IMG-509
ClassificationSmall molecules
Mechanisms of ActionCannabinoid receptor modulatorsHIV replication inhibitors
TargetsCannabinoid receptor
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmugen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmugen Pharmaceuticals IncSouthern Research Institute
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A